A 2021 study by Georgetown University Health Policy Institute Center found that during the COVID-19 special enrollment period online enrollment…
On November 12, 2021, the Centers for Medicare and Medicaid Services (CMS) announced that premiums for Medicare Part B would…
On November 1, 2021, the Alliance for Mental Healthcare Access (AMHCA) submitted a letter to Senator Ron Wyden and Senator…
A frequent criticism in the healthcare accessibility discussion is prescription drug pricing in the United States, and often the claim that prescription drug pricing is outpacing the cost of…
A recent article by HealthPayer Intelligence found that only 40 of 180 insurance companies surveyed were familiar with prescription digital therapeutics (PDTs). Further, the survey found…
The pandemic has highlighted racial disparities, with rates of severe illness and death resulting from COVID-19 disproportionately higher among people of color. A recent Health Affairs…
Recently, the Alliance for Patient Access (AfPA) published a blog titled Prescription Digital Therapeutics Emerge as Health Care’s Newest Frontier. The blog highlights how…
On October 28, 2021, Aimed Alliance’s multidisciplinary stakeholder group, ACTION for PDTs in collaboration with the ACTION for PDTs’ California Working Group, released two new California-focused resources on…
On October 8, 2021, California Governor Gavin Newsom announced that he would be vetoing SB 110. SB 110 would have allowed the California state…
The Massachusetts Medicaid and Children’s Health Insurance Program, known as MassHealth, announced that effective November 1, 2021, MassHealth would begin covering…